-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Akoya Biosciences, Lowers Price Target to $1.08

Benzinga·05/19/2025 15:13:55
Listen to the news
Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:AKYA) with a Hold and lowers the price target from $1.8 to $1.08.